Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-24 @ 11:10 PM
NCT ID:
NCT02256969
Eligibility Criteria:
Inclusion Criteria:
* Age 18-89 years
* Willing and able to provide written informed consent
* Willing and able to comply with study assessments for the full duration of the study
* Diagnosis of meibomian gland dysfunction (MGD)
* Symptoms of MGD such as foreign body sensation, burning, stinging, light sensitivity for at least 3 months
* Persistent symptoms despite at least 3 months of medical management including lid hygiene, warm compress, and use of topical and systemic therapy, or contraindication to systemic therapy
* Presence of lid tenderness on the upper lids in both eyes
* Tear break-up time (TBUT) of \<10 seconds
* In good stable overall health
Exclusion Criteria:
* Active allergies to steroids, sulfacetamide, GenTeal PM Night-Time ointment, or lidocaine
* Intraocular surgery or ocular laser surgery within 1 month before enrollment
* History of ocular infection within 1 month before enrollment.
* History of increased intraocular pressure after using topical steroids (steroid responsive)
* Any condition (including language barrier) that precludes subject's ability to comply with study requirements including completion of study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT02256969
Study Brief:
Protocol Section:
NCT02256969